Cargando…
New and Emerging Targeted Therapies for Advanced Breast Cancer
In the United States, breast cancer is among the most frequently diagnosed cancers in women. Breast cancer is classified into four major subtypes: human epidermal growth factor receptor 2 (HER2), Luminal-A, Luminal-B, and Basal-like or triple-negative, based on histopathological criteria including t...
Autores principales: | Lau, Kristie H., Tan, Alexandra M., Shi, Yihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874375/ https://www.ncbi.nlm.nih.gov/pubmed/35216405 http://dx.doi.org/10.3390/ijms23042288 |
Ejemplares similares
-
Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer
por: Shi, Jinhong, et al.
Publicado: (2020) -
Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer
por: Canale, Matteo, et al.
Publicado: (2021) -
Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2021) -
Advances in targeted therapies and new promising targets in esophageal cancer
por: Belkhiri, Abbes, et al.
Publicado: (2015) -
Emerging Novel Combined CAR-T Cell Therapies
por: Nguyen, Anh, et al.
Publicado: (2022)